🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Eli Lilly and Company

LLY Healthcare
$1,129.35 $-3.65 (-0.32%)
Market Cap: $1.01 T
Gurus Holding
19
Popularity Rank
#46
% of Shares Held
0.82%
Net Activity (Q1 2026)
+$536.44 M

Guru Ownership Trend

Guru Analysis for Eli Lilly and Company (LLY)

Eli Lilly and Company (LLY), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q1 2026, a total of 19 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.21 B.

Top institutional holders include Ken Fisher and Cliff Asness.

Institutional sentiment is currently Strongly Bullish. This is evidenced by a $536.44 M net inflow during the quarter.

Recent activity highlights Paul Tudor Jones who increased their stake by 166.6%. Conversely, Jefferies Group reduced exposure by 61.8%.

Key Holders

Top 5 by Value

$4.45 B
$785.71 M
$689.66 M
$300.13 M
$114.67 M

Top 5 by Conviction

Recent Activity Breakdown (Q1 2026)

+$689.13 M
Total Buy Value
New Buys 2
Additions 10
-$152.69 M
Total Sell Value
Reductions 6
Sold Out 1

Guru Consensus (Q1 2026)

Based on recent activity
Net Sellers
7
Net Buyers
12

FAQs for Eli Lilly and Company (LLY)

Major holders include Ken Fisher ($4.45 B), Cliff Asness ($785.71 M), Jeremy Grantham ($689.66 M). According to the latest reported data, 19 tracked investment managers collectively hold approximately 7.27 M shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $536.44 M, with 12 managers increasing positions and 7 managers reducing holdings.

During the most recent reporting period, 6 managers trimmed their positions, while 1 fully exited LLY. The total reported sell value was $152.69 M.

Yes, 2 managers opened new positions in LLY, and 10 increased their existing holdings. The total reported buy value was $689.13 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
1.51% Add 5.1% 4,838,986 $4.45 B Q1 2026
0.36% Add 68.8% 855,420 $785.71 M Q1 2026
1.76% Add 1.4% 749,815 $689.66 M Q1 2026
3.07% Reduce -5.5% 326,306 $300.13 M Q1 2026
0.21% Add 166.6% 124,672 $114.67 M Q1 2026
0.11% Add 41.4% 95,766 $88.08 M Q1 2026
0.10% Reduce -56.7% 71,788 $66.03 M Q1 2026
0.29% Reduce -3.4% 70,812 $65.13 M Q1 2026
0.12% New Buy 32,887 $30.25 M Q1 2026
0.24% Add 5.9% 26,339 $24.23 M Q1 2026
0.15% Reduce -61.8% 23,030 $21.18 M Q1 2026
0.22% Reduce -0.6% 22,199 $20.42 M Q1 2026
0.05% Add 43.0% 16,175 $14.88 M Q1 2026
0.09% New Buy 12,676 $11.66 M Q1 2026
0.04% Reduce -3.4% 3,965 $3.65 M Q1 2026
0.53% 2,000 $1.84 M Q1 2026
0.08% Add 2.8% 579 $532,547 Q1 2026
0.04% Add 29.4% 423 $389,122 Q1 2026
0.00% Add 9.8% 45 $39,898 Q1 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form